This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded Bristol-Myers Squibb.
MOdelling the NAtural histoRy and Cost-effectiveness of Hepatitis
Reference
McEwan P, et al. Assessing the cost utility of response-guided therapy in patients with chronic hepatitis C genotype 1 in the UK using the MONARCH Model. Applied Health Economics and Health Policy : 14 Nov 2012
Rights and permissions
About this article
Cite this article
Response-guided protocol rules in the UK. PharmacoEcon Outcomes News 671, 9 (2013). https://doi.org/10.1007/s40274-013-0142-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0142-y